CD8A and Ascites: - OV reduced ascites formation and prolonged survival in mice- Enhanced T cell infiltration and activation (especially CD8+ T cells)- Reprogrammed the immune microenvironment toward proinflammatory status- Combination therapy (OV + anti-PD-1 + PLX3397) further improved T cell activity and delayed ascites progression